<?xml version="1.0" encoding="UTF-8"?>
<ref id="B111">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tan</surname>
    <given-names>T. K.</given-names>
   </name>
   <name>
    <surname>Rijal</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rahikainen</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Keeble</surname>
    <given-names>A. H.</given-names>
   </name>
   <name>
    <surname>Schimanski</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hussain</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2021</year>). 
  <article-title>A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses</article-title>. 
  <source>Nat. Commun.</source>
  <volume>12</volume> (
  <issue>1</issue>), 
  <fpage>542</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41467-020-20654-7</pub-id>
  <pub-id pub-id-type="pmid">33483491</pub-id>
 </mixed-citation>
</ref>
